U.S. market Closed. Opens in 2 days 55 minutes

REVBW | Revelation Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue25.05K40.01K69.17KN/AN/A
Gross Profit-25.05K-40.01K-69.17KN/AN/A
Operating Expenses8.63M10.86M11.95M145.49K3.64K
Selling, General & Admin4.49M5.49M5.04M145.49K3.64K
Research & Development4.15M5.38M6.91M2.56MN/A
Other Operating ExpensesN/A34.96K-36.35KN/AN/A
Operating Income-8.66M-10.86M-11.95M-145.49K-3.64K
Other Expenses / Income8.54M34.96K-36.35K-1.49M2.00
Before Tax Income-120.25K-10.83M-11.99M-1.63M-3.64K
Income Tax Expenses1.00-34.96K-219.78K-3.79K-171.86K
Net Income-120.25K-10.79M-11.99M-1.63M-3.64K
Interest ExpensesN/A-34.96K-41.76KN/AN/A
Basic Shares Outstanding228.00K538.50K369.83K8.66K8.66K
Diluted Shares Outstanding228.64K538.50K369.83K8.66K8.66K
EBITDA-8.63M-10.84M-11.93M-145.49K-3.64K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-120.25K-10.86M-12.25M-1.63M-175.50K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙